Rohit Singh

Good evening Sir. Congrats for a good set of n umbers. My question is do you see any kind of near to medi um term risk either due to Red Sea crisis or any other specific reason to maintain our growth trajectory going ahead because like you mentioned in your presentation as well due to Red Sea crisis we have been shifted to CIF model from FOB model so can you please put some color on that what is the situation right…

That seems good and Sir like you mentioned about the biologics importing into India and then doing some clinical trials so can you put some more color like what kind of opportunity do you see here or whether it will be done via Caplin Steriles or we are looking for a new facility their own?